Veradermics, Incorporated Common Stock (MANE)

Total Costs & Expenses

$29.55M

Quarterly · Period ending: · USD

MANE logo

MANE Total Costs & Expenses

Latest reported$29.55M
MANE Quarterly Total Costs & Expenses ($5.97M → $29.55M)
High-resolution chart · PNG

MANE total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Veradermics, Incorporated Common Stock Total Costs & Expenses — Quarterly (USD)
Period endingTotal Costs & Expenses (USD)
29,553,000
29,862,000
23,011,000
20,348,000
16,073,000
12,915,000
5,971,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.